<DOC>
	<DOCNO>NCT01514305</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety Dexcom G4 System use adjuvant blood glucose test . Device performance primarily evaluate term proportion glucose value within pre-specified range compare reference value . Safety data G4 System also collect vis-a-vis adverse event report characterize incidence severity Serious Adverse Device Events , Adverse Device Events experience study participant .</brief_summary>
	<brief_title>Observational Study Evaluate Effectiveness Safety Study Dexcom G4â„¢ Continuous Glucose Monitoring System</brief_title>
	<detailed_description />
	<criteria>1 . Age 18 year old ; 2 . Have diagnose insulinrequiring diabetes 3 . Abstain injecting insulin wear insulin pump insertion set within 3 inch sensor site sensor wear ; 4 . Insert sensor wear 2 system simultaneously ; 5 . Use blood glucose meter provide blood glucose measurement perform sensor wear allow others use meter study ; 6 . Participate one inclinic session comprise fingersticks per hour blood draw entire inclinic session ; 7 . Have intravenous catheter insert 4 blood draw per hour 8 . Willing perform SMBG home use meter provide ; 9 . Refrain use acetaminophen sensor wear period day prior sensor insertion ; 10 . Speak , read , write English ; 11 . Willing able compliant provision lay protocol . 1 . Have extensive skin changes/diseases preclude wear device normal skin ( e.g. , extensive psoriasis , recent burn severe sunburn , extensive eczema , extensive scarring , extensive tattoo , dermatitis herpetiformis ) propose wear site ; 2 . Allergy medicalgrade adhesive ; 3 . Pregnant demonstrate positive pregnancy test within 72 hour sensor insertion , 4 . Dialysis treatment ; 5 . Hematocrit outside range 3055 % screen visit ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>